drugset / Trial / NCT02646800
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of intravenous micafungin for the treatment of adult patients in China infected by Candida spp or Aspergillus spp.
Timeline
- Start
- 2014-03-21
- Primary completion
- 2014-12-21
- Completion
- 2014-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Micafungin | Peptide | — | Intravenous |